摘要
全球范围内,胃癌是导致与癌症相关的死亡的第二大主要原因。胃癌被发现时往往是晚期,对其治疗已困难。早期发现胃癌的生物标志物和治疗胃癌的药物靶点是对胃癌有效治疗的关键。分泌蛋白不仅在肿瘤的进展和转移中发挥着不可或缺的作用,而且易于获得。因此,肿瘤微环境中的分泌蛋白是引起关注的生物标志物和药物靶点的来源。在这项研究中,用基于iTRAQ的液相色谱/串联质谱法比较分析11胃癌细胞株和正常胃上皮细胞株的分泌蛋白质组谱。与正常细胞相比,在一个或多个胃癌细胞株检测到接近800种蛋白质,检测到约600种蛋白质显示差异表达。这些差异表达的蛋白主要有结合或酶活性,主要与细胞和代谢过程相关。确认了胃癌细胞株ARPC4的过度表达,并在体外证实胃癌细胞的迁移和侵袭的新功能。本研究的结果支持ARPC4作为转移性胃癌的潜在生物标志物和药物靶点的见解。
关键词: ARPC4,胃癌,分泌蛋白质组,迁移,侵袭。
Current Cancer Drug Targets
Title:Comparative Proteomic Profiling of Extracellular Proteins between Normal and Gastric Cancer Cells
Volume: 16 Issue: 5
Author(s): Mulina Kang, Ssuyi Lu, Poh Kuan Chong, Khay Guan Yeoh, Yoon Pin Lim
Affiliation:
关键词: ARPC4,胃癌,分泌蛋白质组,迁移,侵袭。
摘要: Gastric cancer is the second leading cause of cancer-related deaths worldwide. Gastric cancer is often detected at a late stage when treatment is difficult. Biomarkers for early detection and drug targets for gastric cancer therapy are critical for effective management of gastric cancer. Secreted proteins not only play integral roles in cancer progression and metastasis, they are also easily accessible. Secreted proteins within the tumor microenvironment are therefore an attractive source of biomarkers and drug targets. In this study, iTRAQ-based liquid chromatography/tandem mass spectrometry was used for comparative profiling of the secretomes of 11 gastric cancer cell lines versus a normal gastric epithelial cell line. Of the close to 800 proteins detected, about 600 proteins were detected to display differential expression in one or more gastric cancer cell lines compared to normal cells. These differentially expressed proteins predominantly have binding or enzymatic activities and are largely associated with cellular and metabolic processes. Overexpression of ARPC4 was validated in gastric cell lines and its novel function in gastric cancer cell migration and invasion demonstrated in vitro. The findings support the notion of ARPC4 as a potential biomarker/drug target for metastatic gastric cancer.
Export Options
About this article
Cite this article as:
Mulina Kang, Ssuyi Lu, Poh Kuan Chong, Khay Guan Yeoh, Yoon Pin Lim , Comparative Proteomic Profiling of Extracellular Proteins between Normal and Gastric Cancer Cells, Current Cancer Drug Targets 2016; 16 (5) . https://dx.doi.org/10.2174/1568009616666151209113606
DOI https://dx.doi.org/10.2174/1568009616666151209113606 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
Role of Immune and Genotoxic Response Biomarkers in Tumor Microenvironment in Cancer Diagnosis and Treatment
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process of exploring and investigating the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, ...read more
Unraveling the Tumor Microenvironment and Potential Therapeutic Targets: Insights from Single-Cell Sequencing and Spatial Transcriptomics
This special issue will focus on unraveling the complexities of the tumor microenvironment (TME) and identifying key biomarkers for potential therapeutic targets using advanced multi-omics techniques, such as single-cell sequencing and spatial transcriptomics. We seek original research and comprehensive reviews that investigate the heterogeneity and dynamics of the TME, emphasizing ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
5-Fluorouracil Loaded Orally Administered WGA-decorated Poly(lacticco- glycolic Acid) Nanoparticles for Treatment of Colorectal Cancer: <i>In Vivo</i> Evaluation
Current Nanomedicine Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
Recent Patents on Anti-Cancer Drug Discovery Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review
Current Topics in Medicinal Chemistry Psoriasis and Vascular Risk : An Update
Current Pharmaceutical Design Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Current Medicinal Chemistry Novel N-Substituted Thiazolidinones as Proton Pump Inhibitors and Potent Anti-Ulcer Agents: SAR Study
Letters in Drug Design & Discovery The Vicious Circle of Leptin and Obesity
Current Nutrition & Food Science Synthesis and Evaluation of Anti-inflammatory and Analgesic Activities of New 1,2,4-triazole Derivatives
Medicinal Chemistry Naringenin and Ellagic Acid Reduce Tetrazolium Salt in the Absence of Cells
The Natural Products Journal Chemistry and Biology of Secondary Metabolites from Aspergillus Genus
The Natural Products Journal PHB in Cardiovascular and Other Diseases: Present Knowledge and Implications
Current Drug Targets Inflammation: A Link Between Hypertension and Atherosclerosis
Current Hypertension Reviews Ghrelin: A Molecular Target for Weight Regulation, Glucose and Lipid Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Indication of Bevacizumab for Cerebral Radiation Necrosis
Recent Patents on Anti-Cancer Drug Discovery Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and Therapy
Current Medicinal Chemistry Suppression of Cancer Invasiveness by Dietary Compounds
Mini-Reviews in Medicinal Chemistry Chronopharmaceutical Delivery of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies
Recent Patents on Anti-Cancer Drug Discovery Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors
Current Medicinal Chemistry Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin
Mini-Reviews in Medicinal Chemistry